Literature DB >> 33686596

Novel "Modified Bascule Method" for Lymphadenectomy Along the Left Recurrent Laryngeal Nerve During Robot-Assisted Minimally Invasive Esophagectomy.

Taro Oshikiri1, Gosuke Takiguchi2, Naoki Urakawa2, Hiroshi Hasegawa2, Masashi Yamamoto2, Shingo Kanaji2, Kimihiro Yamashita2, Takeru Matsuda3, Tetsu Nakamura2, Satoshi Suzuki4, Yoshihiro Kakeji2.   

Abstract

BACKGROUND: Given the worldwide popularization of conventional minimally invasive esophagectomy (C-MIE), robot-assisted MIE (RAMIE) can be expected to provide a finer procedure. However, controversy remains regarding whether RAMIE is superior to C-MIE in preventing recurrent laryngeal nerve (RLN) palsy. Considering the shallow learning curve for RAMIE, a novel procedure for lymphadenectomy along the RLN during RAMIE is needed.
METHODS: Based on a logical and simple understanding of the left upper mediastinum anatomy, the authors developed a novel "modified bascule method" for RAMIE that could simplify lymphadenectomy along the left RLN and prevent it from being touched and stretched. Between 2018 and 2020, 46 patients with esophageal carcinoma underwent RAMIE using this method at Kobe University.
RESULTS: The modified bascule method was used to perform RAMIE for 29 men and 17 women with a median age of 67 years (range, 49-82 years). The median thoracoscopic procedure time was 438 min (range, 344-625 min), and the median console time was 351 min (range 273-518 min). The study harvested a median of 24 (range, 8-34) lymph nodes from the thoracic portion and 4 (range, 0-10) lymph nodes from along the left RLN. The mortality rate was 0%. Postoperative left RLN palsy classified as Clavien-Dindo (C-D) grade 1 or higher was observed for 9 patients (19%), whereas grade 2 or higher was not seen (0%). Pneumonia and anastomotic leakage rates higher than C-D grade 2 were respectively 13% and 19%.
CONCLUSIONS: The novel modified bascule method for RAMIE can promote feasible lymphadenectomy along the left RLN even when performed during the learning period.
© 2021. Society of Surgical Oncology.

Entities:  

Year:  2021        PMID: 33686596     DOI: 10.1245/s10434-021-09738-w

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  4 in total

1.  Endoscopic oesophagectomy through a right thoracoscopic approach.

Authors:  A Cuschieri; S Shimi; S Banting
Journal:  J R Coll Surg Edinb       Date:  1992-02

2.  Comment on "Organ Preservation in cT2N0 Rectal Cancer After Neoadjuvant Chemoradiation Therapy".

Authors:  Yoshiaki Kanemoto; Tomohiro Kurokawa; Tetsuya Tanimoto
Journal:  Ann Surg       Date:  2019-12       Impact factor: 12.969

3.  Trends in oesophageal resection for carcinoma with special reference to total oesophagectomy.

Authors:  K C McKeown
Journal:  Ann R Coll Surg Engl       Date:  1972-10       Impact factor: 1.891

4.  Worldwide Techniques and Outcomes in Robot-assisted Minimally Invasive Esophagectomy (RAMIE): Results From the Multicenter International Registry.

Authors:  B Feike Kingma; Peter P Grimminger; Pieter C van der Sluis; Marc J van Det; Ewout A Kouwenhoven; Yin-Kai Chao; Chun-Yi Tsai; Hans F Fuchs; Christiane J Bruns; Inderpal S Sarkaria; James D Luketich; Jan W Haveman; Boudewijn van Etten; Philip W Chiu; Shannon M Chan; Philippe Rouanet; Anne Mourregot; Jens-Peter Hölzen; Rubens A Sallum; Ivan Cecconello; Jan-Hendrik Egberts; Frank Benedix; Mark I van Berge Henegouwen; Suzanne S Gisbertz; Daniel Perez; Kristina Jansen; Michal Hubka; Donald E Low; Matthias Biebl; Johann Pratschke; Paul Turner; Kish Pursnani; Asif Chaudry; Myles Smith; Elena Mazza; Paolo Strignano; Jelle P Ruurda; Richard van Hillegersberg
Journal:  Ann Surg       Date:  2020-11-09       Impact factor: 13.787

  4 in total
  1 in total

1.  Robot-assisted minimally invasive esophagectomy versus video-assisted minimally invasive esophagectomy: a systematic review and meta-analysis.

Authors:  Hao Chen; Yiyang Liu; Hao Peng; Rongchun Wang; Kang Wang; Demin Li
Journal:  Transl Cancer Res       Date:  2021-11       Impact factor: 1.241

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.